GETI.B

212

+0.14%↑

CAMX

687.5

-5.76%↓

BIOAB

267.6

-1.18%↓

VITR

134.5

-0.15%↓

EKTA.B

49.72

-0.32%↓

GETI.B

212

+0.14%↑

CAMX

687.5

-5.76%↓

BIOAB

267.6

-1.18%↓

VITR

134.5

-0.15%↓

EKTA.B

49.72

-0.32%↓

GETI.B

212

+0.14%↑

CAMX

687.5

-5.76%↓

BIOAB

267.6

-1.18%↓

VITR

134.5

-0.15%↓

EKTA.B

49.72

-0.32%↓

GETI.B

212

+0.14%↑

CAMX

687.5

-5.76%↓

BIOAB

267.6

-1.18%↓

VITR

134.5

-0.15%↓

EKTA.B

49.72

-0.32%↓

GETI.B

212

+0.14%↑

CAMX

687.5

-5.76%↓

BIOAB

267.6

-1.18%↓

VITR

134.5

-0.15%↓

EKTA.B

49.72

-0.32%↓

Search

Vivesto AB

Cerrado

0

Resumen

Variación precio

24h

Actual

Mínimo

Máximo

Métricas clave

By Trading Economics

Ingresos

-1.2M

-9.5M

BPA

-0.018

Empleados

4

Dividendos

By Dow Jones

Próximas Ganancias

11 nov 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

11M

141M

Apertura anterior

0

Cierre anterior

0

Vivesto AB Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

15 sept 2025, 22:39 UTC

Adquisiciones, fusiones, absorciones

CSL Agrees to Deal to Advance Coagulation Treatment, May Acquire Developer

15 sept 2025, 16:43 UTC

Principales Movimientos del Mercado

Strive Shares Sink on Board Disclosure; Bitcoin Treasury Strategy

15 sept 2025, 16:42 UTC

Principales Movimientos del Mercado

Helius Medical Tech Jumps on Funding to Launch Solana Treasury

15 sept 2025, 16:35 UTC

Principales Movimientos del Mercado

Chegg to Pay $7.5 Million to Settle FTC Claims Over Subscription Cancellation Process

15 sept 2025, 23:46 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

15 sept 2025, 23:46 UTC

Charlas de Mercado

Nikkei May Rise as Fed Rate Cut Hopes Support Stocks -- Market Talk

15 sept 2025, 23:34 UTC

Charlas de Mercado

Gold Steady Ahead of FOMC Meeting, Major U.S. Economic Data -- Market Talk

15 sept 2025, 22:48 UTC

Charlas de Mercado

FOMC May Opt to Play Catch Up With Rate Cuts -- Market Talk

15 sept 2025, 22:12 UTC

Adquisiciones, fusiones, absorciones

CSL Expects Commercial Launch in 2029

15 sept 2025, 22:12 UTC

Adquisiciones, fusiones, absorciones

CSL Says VarmX to Receive Further Commercial Milestones Afterwards

15 sept 2025, 22:11 UTC

Adquisiciones, fusiones, absorciones

CSL Says VarmX to Receive Payments of Up to $388 Million Up to Launch of VMX-C001

15 sept 2025, 22:11 UTC

Adquisiciones, fusiones, absorciones

CSL to Have Right to Exercise Option Based on Phase 3 Data

15 sept 2025, 22:10 UTC

Adquisiciones, fusiones, absorciones

CSL to Make Upfront Payment to VarmX of $117 Million for Exclusive Option to Acquire Company

15 sept 2025, 21:16 UTC

Adquisiciones, fusiones, absorciones

Chord Energy: Assets Have a Low Avg NYMEX WTI Breakeven and Are Immediately Competitive for Capital

15 sept 2025, 21:16 UTC

Adquisiciones, fusiones, absorciones

Chord Energy: Assets Have Significant Overlap With Existing Footprint, Setting the Stage for Long-Lateral Development

15 sept 2025, 21:15 UTC

Adquisiciones, fusiones, absorciones

Chord Energy to Buy 48,000 Net Acres in the Williston Core

15 sept 2025, 21:14 UTC

Adquisiciones, fusiones, absorciones

Chord Energy to Buy Assets in Williston Basin From Exxon's XTO Energy and Affiliates for $550M

15 sept 2025, 20:50 UTC

Charlas de Mercado

Auto & Transport Roundup: Market Talk

15 sept 2025, 20:50 UTC

Charlas de Mercado

Financial Services Roundup: Market Talk

15 sept 2025, 20:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

15 sept 2025, 19:29 UTC

Charlas de Mercado

U.S. Natural Gas Gains on Warmer Weather Outlook -- Market Talk

15 sept 2025, 19:14 UTC

Charlas de Mercado

Attacks on Russia Lifts Oil Price Despite Shaky Fundamentals -- Market Talk

15 sept 2025, 18:16 UTC

Charlas de Mercado

Gold Powers to New High -- Market Talk

15 sept 2025, 18:05 UTC

Charlas de Mercado

Easing Autonomous Vehicle Regulations Will Begin Tesla's Next Chapter -- Market Talk

15 sept 2025, 17:50 UTC

Adquisiciones, fusiones, absorciones

U.S. Reaches Outline of Deal With China Over TikTok -- 2nd Update

15 sept 2025, 17:10 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

15 sept 2025, 17:10 UTC

Charlas de Mercado

S&P Expects Fed, BOC to Cut Rates -- Market Talk

15 sept 2025, 16:52 UTC

Charlas de Mercado

Copper Climbs as Traders Brace for U.S. Rate Cut -- Market Talk

15 sept 2025, 16:20 UTC

Charlas de Mercado

Financial Services Roundup: Market Talk

15 sept 2025, 16:20 UTC

Charlas de Mercado
Ganancias

Auto & Transport Roundup: Market Talk

Comparación entre iguales

Cambio de precio

Vivesto AB previsión

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Vivesto AB

Vivesto AB develops, produces, markets, and sells drugs in the field of human and veterinary oncology in Sweden. Its lead product is Apealea (paclitaxel micellar) for the treatment of ovarian cancer. The company's products portfolio includes Docetaxel micellar, a patented formulation that combines cytotoxin docetaxel with XR-17, which is in Phase 1b clinical trial for the treatment of prostate cancer; and Cantrixil to treat ovarian cancer. its animal health product portfolio includes Paccal Vet, a formulation of paclitaxel with its XR-17 encapsulation technology for the treatment of canine mastocytoma; and Doxophos Vet, a patented formulation of doxorubicin to treat lymphoma. The company was formerly known as Oasmia Pharmaceutical AB (publ) and changed its name to Vivesto AB in March 2022. Vivesto AB was incorporated in 1988 and is headquartered in Solna, Sweden.
help-icon Live chat